Fructosamine Test

Fructosamine is a molecule that forms when glucose, a simple sugar in your blood, attaches to proteins like albumin without the help of enzymes. This process, called non-enzymatic glycation, reflects how much glucose has been binding to your blood proteins over the past 2 to 3 weeks.

Because blood proteins such as albumin have a much shorter lifespan than red blood cells (about 2 to 3 weeks compared to 3 to 4 months), fructosamine levels can respond more quickly to changes in your blood sugar. This makes fructosamine a useful marker for assessing short-term glycemic control, giving you a snapshot of how well your blood sugar has been managed recently.

Typically, long-term blood sugar control is monitored with a test called HbA1c, which reflects average blood glucose over 2 to 3 months. However, certain conditions that affect red blood cells, such as anemia, sickle cell disease, or recent blood loss, can make HbA1c readings unreliable. In these situations, fructosamine provides a valuable alternative for tracking blood sugar levels.

It is important to know that fructosamine levels depend not only on blood sugar but also on blood protein levels. Conditions like nephrotic syndrome (a kidney disorder that causes protein loss) or multiple myeloma (a cancer of plasma cells) can alter fructosamine results independently of glucose control. Because of this, interpreting fructosamine results always requires careful consideration of a person’s overall protein health.

Despite its advantages, fructosamine testing is not as widely used as HbA1c. There are fewer large clinical studies validating its ability to predict long-term diabetes complications, and there is no universal agreement on target ranges. In addition, anything that lowers or raises blood protein levels can affect fructosamine test results, which can make interpretation more complex.